Jordi Camps

9.9k total citations
252 papers, 7.1k citations indexed

About

Jordi Camps is a scholar working on Clinical Biochemistry, Epidemiology and Surgery. According to data from OpenAlex, Jordi Camps has authored 252 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Clinical Biochemistry, 65 papers in Epidemiology and 51 papers in Surgery. Recurrent topics in Jordi Camps's work include Paraoxonase enzyme and polymorphisms (77 papers), Liver Disease Diagnosis and Treatment (45 papers) and Apelin-related biomedical research (20 papers). Jordi Camps is often cited by papers focused on Paraoxonase enzyme and polymorphisms (77 papers), Liver Disease Diagnosis and Treatment (45 papers) and Apelin-related biomedical research (20 papers). Jordi Camps collaborates with scholars based in Spain, United States and United Kingdom. Jordi Camps's co-authors include Jorge Joven, Judit Marsillach, Natàlia Ferré, Anna Rull, Carlos Alonso‐Villaverde, Raúl Beltrán‐Debón, Gerard Aragonès, Bharti Mackness, Anna Hernández‐Aguilera and Joan Rodés and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Jordi Camps

243 papers receiving 6.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jordi Camps Spain	46	2.0k	1.7k	1.4k	1.2k	934	252	7.1k
Jorge Joven Spain	62	2.1k 1.1×	1.8k 1.1×	3.9k 2.7×	1.9k 1.5×	282 0.3×	377	12.2k
Gianna Ferretti Italy	41	995 0.5×	845 0.5×	1.1k 0.8×	1.0k 0.8×	276 0.3×	155	5.6k
Sydney Tang Hong Kong	51	578 0.3×	974 0.6×	2.0k 1.4×	1.1k 0.9×	480 0.5×	314	9.4k
James E. Heubi United States	48	531 0.3×	1.0k 0.6×	1.2k 0.9×	2.5k 2.0×	571 0.6×	174	8.5k
Pasquale Pignatelli Italy	57	287 0.1×	1.4k 0.8×	2.0k 1.4×	1.7k 1.4×	261 0.3×	349	11.0k
Daniel J. Antoine United Kingdom	37	1.4k 0.7×	1.1k 0.7×	1.6k 1.1×	418 0.3×	872 0.9×	75	5.6k
Giovanni Li Volti Italy	50	269 0.1×	1.3k 0.7×	3.5k 2.5×	765 0.6×	373 0.4×	288	8.3k
Natàlia Ferré Spain	36	682 0.3×	978 0.6×	664 0.5×	438 0.4×	172 0.2×	103	3.9k
Han Moshage Netherlands	53	248 0.1×	3.2k 1.8×	2.8k 1.9×	1.9k 1.5×	1.9k 2.0×	196	9.9k
Sridevi Devaraj United States	75	854 0.4×	5.1k 2.9×	4.0k 2.8×	3.2k 2.6×	266 0.3×	320	16.5k

Countries citing papers authored by Jordi Camps

Since Specialization

Citations

This map shows the geographic impact of Jordi Camps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Camps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Camps more than expected).

Fields of papers citing papers by Jordi Camps

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Camps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Camps. The network helps show where Jordi Camps may publish in the future.

Co-authorship network of co-authors of Jordi Camps

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Camps. A scholar is included among the top collaborators of Jordi Camps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Camps. Jordi Camps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camps, Jordi, et al.. (2025). Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus. Biomolecules. 15(7). 1027–1027.

Pujol, Isabel, Simona Iftimie, Jordi Camps, et al.. (2025). Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia. Chemico-Biological Interactions. 418. 111606–111606.

Castañé, Helena, et al.. (2024). Preliminary Metabolomics Study Suggests Favorable Metabolic Changes in the Plasma of Breast Cancer Patients after Surgery and Adjuvant Treatment. Biomedicines. 12(10). 2196–2196. 2 indexed citations

Iftimie, Simona, et al.. (2024). Retrospective Analysis of Clostridioides difficile Infection Rates and Outcomes in Hospitalized Patients during the COVID-19 Pandemic: A Unicenter Study in Reus, Spain. Journal of Clinical Medicine. 13(10). 2799–2799. 1 indexed citations

Murcia, M., Joan R. Badia, Helena Castañé, et al.. (2024). Combining Metabolomics and Machine Learning to Identify Diagnostic and Prognostic Biomarkers in Patients with Non-Small Cell Lung Cancer Pre- and Post-Radiation Therapy. Biomolecules. 14(8). 898–898. 2 indexed citations

Iftimie, Simona, Ana F. López‐Azcona, Helena Castañé, et al.. (2024). Serum Levels of Arachidonic Acid, Interleukin-6, and C-Reactive Protein as Potential Indicators of Pulmonary Viral Infections: Comparative Analysis of Influenza A, Respiratory Syncytial Virus Infection, and COVID-19. Viruses. 16(7). 1065–1065. 1 indexed citations

Baiges‐Gayà, Gerard, Simona Iftimie, Helena Castañé, et al.. (2023). Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19. Biomolecules. 13(1). 163–163. 11 indexed citations

Riu, Francesc, Gabriel de Febrer, Jordi Camps, et al.. (2023). SARS-CoV-2 Serum Viral Load and Prognostic Markers Proposal for COVID-19 Pneumonia in Low-Dose Radiation Therapy Treated Patients. Journal of Clinical Medicine. 12(3). 798–798. 4 indexed citations

Castañé, Helena, Anna Hernández‐Aguilera, Salvador Fernández‐Arroyo, et al.. (2023). Metabolic adaptations in severe obesity: Insights from circulating oxylipins before and after weight loss. Clinical Nutrition. 43(1). 246–258. 10 indexed citations

10.

Rodríguez‐Tomàs, Elisabet, Meritxell Arenas, Gerard Baiges‐Gayà, et al.. (2022). Gradient Boosting Machine Identified Predictive Variables for Breast Cancer Patients Pre- and Post-Radiotherapy: Preliminary Results of an 8-Year Follow-Up Study. Antioxidants. 11(12). 2394–2394. 6 indexed citations

11.

Camps, Jordi, Helena Castañé, Elisabet Rodríguez‐Tomàs, et al.. (2021). On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update. Biomolecules. 11(7). 971–971. 25 indexed citations

12.

Rodríguez‐Tomàs, Elisabet, Simona Iftimie, Helena Castañé, et al.. (2021). Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach. Antioxidants. 10(6). 991–991. 14 indexed citations

13.

Povedano, Eloy, Víctor Ruiz‐Valdepeñas Montiel, Alejandro Valverde, et al.. (2018). Versatile Electroanalytical Bioplatforms for Simultaneous Determination of Cancer-Related DNA 5-Methyl- and 5-Hydroxymethyl-Cytosines at Global and Gene-Specific Levels in Human Serum and Tissues. ACS Sensors. 4(1). 227–234. 65 indexed citations

14.

Fort-Gallifa, Isabel, Anna Hernández‐Aguilera, Anabel García‐Heredia, et al.. (2017). Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation. International Journal of Molecular Sciences. 18(5). 973–973. 35 indexed citations

15.

Riera-Borrull, Marta, Anabel García‐Heredia, Salvador Fernández‐Arroyo, et al.. (2017). Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study. International Journal of Molecular Sciences. 18(11). 2263–2263. 18 indexed citations

16.

Hernández‐Aguilera, Anna, Esther Rodríguez‐Gallego, María Guirro, et al.. (2015). Immunohistochemical Analysis of Paraoxonases and Chemokines in Arteries of Patients with Peripheral Artery Disease. International Journal of Molecular Sciences. 16(5). 11323–11338. 23 indexed citations

17.

Rodríguez‐Gallego, Esther, María Guirro, Marta Riera-Borrull, et al.. (2014). Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease. International Journal of Obesity. 39(2). 279–287. 70 indexed citations

18.

Alonso‐Villaverde, Carlos, Gerard Aragonès, Raúl Beltrán‐Debón, et al.. (2010). Host–pathogen interactions in the development of metabolic disturbances and atherosclerosis in HIV infection: The role of CCL2 genetic variants. Cytokine. 51(3). 251–258. 13 indexed citations

19.

Cabré, María, Jordi Camps, Natàlia Ferré, J. L. Paternain, & Jorge Joven. (2001). The Antioxidant and Hepato-Protective Effects of Zinc are Related to Hepatic Cytochrome P450 Depression and Metallothionein Induction in Rats with Experimental Cirrhosis. International Journal for Vitamin and Nutrition Research. 71(4). 229–236. 15 indexed citations

20.

Joven, Jorge, et al.. (1997). Lipoprotein alterations in liver cirrhosis: a possible contribution to changes in plasma oncotic pressure and viscosity. Journal of Hepatology. 27(4). 639–644. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact